In this review:
Active surveillance for prostate cancer
Selecting prostate cancer patients for active surveillance
Prostate cancer genetics in the 21st century
Somatic genetics and implications for care
Treatment selection after AR-directed therapy
Role of biomarkers in sequencing and selecting systemic therapy
ProPSMA trial: developing a new gold standard
Should PSMA-PET be performed prebiopsy?
Theranostic opportunities
Best practice penile rehabilitation
Please login below to download this issue (PDF)